Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-53.52	24.90	53.57
Graham Fair Price	49.35	16109.50	10786.60
PEG	-61.11	0.04	-0.10
Price/Book	-25.39	0.52	0.70
Price/Cash Flow	-195.78	-21.40	-7.24
Prices/Earnings	-64.61	4.68	13.23
Price/Sales	-32.34	0.60	0.89
Price/FCF	-195.78	-21.40	-7.24
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	19.02	0.25	0.21
Operating Margin	175.22	0.09	0.03
ROA	111.56	< 0.005	< 0.005
ROE	0.01	0.03	110.83
ROIC	< 0.005	0.01	200.54
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.07	0.17	-60.38
Dividends QOQ	0.00	8.65	100.00
EBIT QOQ	1.62	2.13	31.45
EPS QOQ	1.28	1.17	-9.00
FCF QOQ	0.45	0.74	65.40
Revenue QOQ	0.41	0.14	-66.62
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	226.18	217.11	-4.01
Days Sales Outstanding (DSO)	145.17	131.85	-9.17
Inventory Turnover	0.40	0.41	4.18
Debt/Capitalization	0.68	0.68	1.04
Quick Ratio	0.48	0.52	8.13
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	19835.42	27891.12	40.61
Cash	2828.31	3585.06	26.76
Capex	-690.44	502.03	-27.29
Free Cash Flow	-1907.00	-494.76	74.06
Revenue	15528.49	17612.89	13.42
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.02	1.06	3.79
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	39.63	19.75	-50.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating